Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
about
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Is there truly a risk of lymphoma from biologic therapies?Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.Lymphoma and metastatic breast cancer presenting with palpable axillary and inguinal lymphadenopathy in a 40-year-old man with rheumatoid arthritis on anti-tumor necrosis factor α therapy: a case report.Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.
P2860
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@ast
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@en
type
label
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@ast
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@en
prefLabel
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@ast
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@en
P2093
P2860
P356
P1476
Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
@en
P2093
A J Silman
D P M Symmons
J P Franklin
P2860
P304
P356
10.1136/ARD.2005.035311
P407
P577
2005-05-01T00:00:00Z